Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”_Chinese Journal of Evidence-Based Medicine

Authors：

WANG Jing ^1,2 , XIAO Guirong ³ , SUN Guorui ⁴ ,  HUANG Zhen ⁴ ,  HU Ming ¹

1. West China School of Pharmacy, Sichuan University, Chengdu 610041, P.R.China;
2. Clinical Research Institute, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, P.R.China;
3. West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
4. Market Supervision Administration of Chengdu Municipality, Chengdu 610041, P.R.China;

Corresponding author：

HUANG Zhen, Email: 723305213@qq.com; HU Ming, Email: huming@scu.edu.cn

Keywords：

Retail pharmacies; Electronic prescriptions; Rational drug use

DOI：

10.7507/1672-2531.202006132

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To evaluate the current situation and rationality of electronic prescription in retail pharmacies in Chengdu, so as to provide references for further improving the sales of prescription drugs in retail drugstores and the level of rational drug use.Methods A set of evaluation index system was constructed, and a prescription review group was set up. Eventually, 7 200 sample electronic prescriptions were collected for retrospective analysis and evaluation.Results Prescriptions from private medical institutions constituted the majority (3 543, 49.21%), and the majority of patients were junior and middle-aged, primarily respiratory diseases (38.24%) and circulatory diseases (17.11%), etc. The average quantity of drugs was 1.60 per prescription, percentage of antimicrobial use was 65.25%, percentage of essential medicines used was 34.92%, and reasonable rate of prescription was 95.21%.Conclusions Electronic prescription services mode for retail pharmacy follows with the trend of “Internet + drug circulation” and complies with the rules of reasonable medical guidance and medication. However, optimizations are required, such as the lack of high-quality medical resources and the urgent need to optimize structure of prescription, and it is still essential to strengthen the management of antibacterial drugs and national essential medicines.

Citation： WANG Jing, XIAO Guirong, SUN Guorui, HUANG Zhen, HU Ming. Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”. Chinese Journal of Evidence-Based Medicine, 2020, 20(11): 1274-1279. doi: 10.7507/1672-2531.202006132 Copy

1.	Verma N, Singh H, Khanna D, et al. Classification of drug molecules for oxidative stress signalling pathway. IET Syst Biol, 2019, 13(5): 243-250.
2.	国家食品药品监督管理局. 药品流通监督管理办法, 2007-01-31. Available at: http://www.gov.cn/gongbao/content/2008/content_934082.htm.
3.	国家食品药品监督管理局. 关于加强零售药店抗菌药物销售监管促进合理用药的通知, 2003-10-24. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20031024010101310.html.
4.	姜明欢, 方宇, 陈文娟, 等. 陕西省药店凭处方销售抗生素现状研究. 中国卫生政策研究, 2013, 6(1): 40-45.
5.	国家卫生计生委等14部门. 遏制细菌耐药国家行动计划(2016-2020年), 2016-08-25. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20160825120001113.html.
6.	管毓向. 零售药店处方药销售管理存在问题初探. 中国卫生产业, 2020, 17(7): 144-146.
7.	蔡旭镇, 黄丽娜, 林晓华, 等. 零售药店安全用药存在的问题及对策. 齐鲁药事, 2008, 27(8): 503-504.
8.	商务部. 全国药品流通行业发展规划(2016-2020年), 2016-12-26. Available at: http://www.mofcom.gov.cn/article/guihua/201612/20161202419508.shtml.
9.	WHO/INRUD. How to investigate drug use in health facility. Selected drug use indicators. Geneva: WHO, 1993: 74.
10.	卫生部. 处方管理办法, 2006-06-14. Available at: http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
11.	卫生部. 医院处方点评管理规范(试行), 2010-02-10. Available at: http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
12.	Bell DS, Friedman MA. E-prescribing and the medicare modernization act of 2003. Health Aff (Millwood), 2005, 24(5): 1159-1169.
13.	Albarrak AI, Al Rashidi EA, Fatani RK, et al. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J, 2014, 22(6): 522-527.
14.	Donyai P, O'Grady K, Jacklin A, et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol, 2008, 65(2): 230-237.
15.	Irani Z, Weerakkody V, Molnar A, et al. A user satisfaction study of the NHS online prescription prepayment certificate. Health Policy Technol, 2014, 3(3): 176-184.
16.	邱皓. 北京市某社区卫生服务中心处方点评结果分析. 中国药事, 2019, 33(12): 1469-1472.
17.	黄猛. 我院2018年门诊处方点评及不合格处方原因分析. 临床医药文献电子杂志, 2019, 6(60): 172-173.
18.	Isah AO, Ross-Degnan D, Quick J, et al. The development of standard values for the WHO drug use prescribing indicators. Geneva: WHO, 1997.
19.	Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: WHO, 1998.
20.	米源, 朱星月, 田燕, 等. 20家基层医疗机构合理用药指标及处方行为研究. 中国药事, 2017, 31(7): 795-801.
21.	朱星月, 田燕, 周乃彤, 等. 四川省各级医疗机构的门诊用药指标实证研究. 药学实践杂志, 2018, 36(1): 40-45.
22.	WHO. Guide to drug financing mechanisms. Geneva: WHO, 1998: 64.
23.	国家卫生健康委. 中国抗菌药物管理和细菌耐药现状报告(2016-2018年), 2019-04-21. Available at: http://www.nhc.gov.cn/yzygj/s3594/201904/1b5a42f0e326487295b260c813da9b0e.shtml.
24.	成都市食品药品监督管理局. 成都市食品药品监督管理局关于在全市药品零售连锁企业中推进电子处方试点工作的通知, 2016-09-20. Available at: http://scjg.chengdu.gov.cn/cdscjgj/c133654/2016-12/05/content_442e1f8c0bf94c73a83897f9cc17a3ee.shtml.
25.	国家卫生健康委. 关于印发抗菌药物临床应用指导原则(2015年版)的通知, 2015-07-24. Available at: http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml.
26.	Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.

1. Verma N, Singh H, Khanna D, et al. Classification of drug molecules for oxidative stress signalling pathway. IET Syst Biol, 2019, 13(5): 243-250.
2. 国家食品药品监督管理局. 药品流通监督管理办法, 2007-01-31. Available at: http://www.gov.cn/gongbao/content/2008/content_934082.htm.
3. 国家食品药品监督管理局. 关于加强零售药店抗菌药物销售监管促进合理用药的通知, 2003-10-24. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20031024010101310.html.
4. 姜明欢, 方宇, 陈文娟, 等. 陕西省药店凭处方销售抗生素现状研究. 中国卫生政策研究, 2013, 6(1): 40-45.
5. 国家卫生计生委等14部门. 遏制细菌耐药国家行动计划(2016-2020年), 2016-08-25. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20160825120001113.html.
6. 管毓向. 零售药店处方药销售管理存在问题初探. 中国卫生产业, 2020, 17(7): 144-146.
7. 蔡旭镇, 黄丽娜, 林晓华, 等. 零售药店安全用药存在的问题及对策. 齐鲁药事, 2008, 27(8): 503-504.
8. 商务部. 全国药品流通行业发展规划(2016-2020年), 2016-12-26. Available at: http://www.mofcom.gov.cn/article/guihua/201612/20161202419508.shtml.
9. WHO/INRUD. How to investigate drug use in health facility. Selected drug use indicators. Geneva: WHO, 1993: 74.
10. 卫生部. 处方管理办法, 2006-06-14. Available at: http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
11. 卫生部. 医院处方点评管理规范(试行), 2010-02-10. Available at: http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
12. Bell DS, Friedman MA. E-prescribing and the medicare modernization act of 2003. Health Aff (Millwood), 2005, 24(5): 1159-1169.
13. Albarrak AI, Al Rashidi EA, Fatani RK, et al. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J, 2014, 22(6): 522-527.
14. Donyai P, O'Grady K, Jacklin A, et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol, 2008, 65(2): 230-237.
15. Irani Z, Weerakkody V, Molnar A, et al. A user satisfaction study of the NHS online prescription prepayment certificate. Health Policy Technol, 2014, 3(3): 176-184.
16. 邱皓. 北京市某社区卫生服务中心处方点评结果分析. 中国药事, 2019, 33(12): 1469-1472.
17. 黄猛. 我院2018年门诊处方点评及不合格处方原因分析. 临床医药文献电子杂志, 2019, 6(60): 172-173.
18. Isah AO, Ross-Degnan D, Quick J, et al. The development of standard values for the WHO drug use prescribing indicators. Geneva: WHO, 1997.
19. Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: WHO, 1998.
20. 米源, 朱星月, 田燕, 等. 20家基层医疗机构合理用药指标及处方行为研究. 中国药事, 2017, 31(7): 795-801.
21. 朱星月, 田燕, 周乃彤, 等. 四川省各级医疗机构的门诊用药指标实证研究. 药学实践杂志, 2018, 36(1): 40-45.
22. WHO. Guide to drug financing mechanisms. Geneva: WHO, 1998: 64.
23. 国家卫生健康委. 中国抗菌药物管理和细菌耐药现状报告(2016-2018年), 2019-04-21. Available at: http://www.nhc.gov.cn/yzygj/s3594/201904/1b5a42f0e326487295b260c813da9b0e.shtml.
24. 成都市食品药品监督管理局. 成都市食品药品监督管理局关于在全市药品零售连锁企业中推进电子处方试点工作的通知, 2016-09-20. Available at: http://scjg.chengdu.gov.cn/cdscjgj/c133654/2016-12/05/content_442e1f8c0bf94c73a83897f9cc17a3ee.shtml.
25. 国家卫生健康委. 关于印发抗菌药物临床应用指导原则(2015年版)的通知, 2015-07-24. Available at: http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml.
26. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.

Previous Article
Analysis on the allocation and equity of medical resources in the five provinces in Northwest China from 2006 to 2017
Next Article
Epidemiological research on inpatients with skin cancer in China

Chinese Journal of Evidence-Based Medicine

Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content